Clinion's decentralized clinical trials and
innovative eClinical platform enhance accessibility, cost
efficiency, ease of use, regulatory compliance, and sustainability
in clinical development.
SAN ANTONIO, July 9, 2024 /PRNewswire/ -- Frost &
Sullivan recently assessed the integrated clinical trial
optimization industry and, based on its findings, recognizes
Clinion with the 2024 North American Technology Innovation
Leadership Award. The company is an innovator in the clinical trial
and data management space. It simplifies clinical trial management
by sharing consistent trial data, leading to accelerated clinical
development, reduced trial costs, increased compliance, and faster
market entry. This technology supports large clientele, small and
medium-sized contract research organizations (CROs) and
Biotechnology medical device and pharmaceutical companies within
the broader life science sector. Its solution portfolio
includes:
- Electronic data capture (EDC)
- Randomization and trial supply management (RTSM)
- Clinical Trial Management System (CTMS)
- Electronic Clinical Outcome Assessment (eCOA)
- Document automation solutions
Clinion's eClinical tools capture high-quality patient data,
advancing trial operations and boosting the efficiency of clinical
development programs. Its cloud-based EDC, RTSM, CTMS, and eCOA
integrated platform offer biopharmaceutical sponsors a unified view
of trial workflows, thus improving efficiency. The company's
AI-enabled eClinical platform employs advanced automation
technologies to speed up clinical study timelines and enhance
visibility into all aspects of the process. The agile and scalable
platform meets the requirements of single-site trials or complex
multi-arm global studies and compliance with regulatory standards
to ensure data safety and integrity. Clinion's advanced AI-enabled
features that complement its current EDC capabilities include:
- eProtocol Automation for effortless protocol creation,
modification, and deployment through an intuitive interface powered
by Generative AI technologies
- Global Libraries - a centralized repository for
study-specific data elements, forms, and designs for copying forms,
editing checks, and skip logic checks to set up studies in
days
- AI Medical Coding for improved data quality and coding
insights that support adept decision-making; it cuts medical coding
time from weeks to a few days and has a 100% match rate and 80%
accuracy
- Remote Source Data Verification Automation for
elimination on-site visits to handle source data verification,
saving time and resources
- Clinical Study Reports (CSR) Automation for
simplifying the creation and, management, of clinical study
reports, accurately changing their tense from future to past and
generating summaries
Aarti Chitale, senior industry
analyst for health and life sciences at Frost & Sullivan,
observed, "Clinion refined its holistic approach to eClinical
solutions, continuously building its platform to bridge industry
gaps. For example, the company distinguishes itself from its
competitors by directly integrating AI functionality into its
platform instead of offering it as an add-on service. This
strategic approach enables Clinion to eliminate manual and
automated processes within its system and replace them with AI
components, thus providing complete end-to-end support for its
clients."
Clinion's intelligent and integrated solutions support
decentralized and virtual hybrid trials, from enhancing remote
patient recruitment, monitoring and engagement to real-world
evidence collection and reporting. Its user-friendly design ensures
an optimal user experience while providing easy access to complex
functionality at an affordable price. The company applies a flat
fee for its services, adopting a pay-as-you-go approach that relies
on the usage duration-on a per-study-per-month basis or on an
annual basis-depending on the client's preference. The company has
actively managed over 500 trials and its ePRO mobile platform has
supported more than 20,000subjects. With operations spanning over
15 countries and involving 300,000 subjects, Clinion engages in
numerous regulatory-approved studies and has contributed to more
than 70 COVID-19 studies. Clinion positions itself strategically in
the market with an industry-leading product that offers tremendous
value in high-demand sectors.
"Clinion's solution streamlines clinical trial management by
covering all phases of the trial process. It serves as a
centralized hub for all trial requirements, including laboratory
data, electronic data capture, and electronic patient-reported
outcomes, to provide improved visibility and control while
eliminating the need for multiple systems, reducing data silos, and
minimizing manual labor," added Riana
Barnard, best practice research analyst at Frost &
Sullivan. Clinion stands out from competitors based on its
commitment to innovation and creativity while achieving commercial
success.
Each year, Frost & Sullivan presents this award to the
company that has developed a product with innovative features and
functionality that is gaining rapid acceptance in the market. The
award recognizes the quality of the solution and the customer value
enhancements it enables.
Frost & Sullivan Best Practices Awards recognize companies
in various regional and global markets for demonstrating
outstanding achievement and superior performance in leadership,
technological innovation, customer service, and strategic product
development. Industry analysts compare market participants and
measure performance through in-depth interviews, analyses, and
extensive secondary research to identify best practices in the
industry.
About Frost & Sullivan
For six decades, Frost
& Sullivan has been world-renowned for its role in helping
investors, corporate leaders, and governments navigate economic
changes and identify disruptive technologies, Mega Trends, new
business models, and companies to action, resulting in a continuous
flow of growth opportunities to drive future success. Contact us:
Start the discussion.
Contact:
Lindsey
Whitaker
P: 937-207-1141
E: lindsey.whitaker@frost.com
About Clinion
Clinion is a global clinical
technology company that offers AI-enabled eClinical solutions
consisting of EDC, RTSM, CTMS, eCOA and Document Automation that
cover the entire clinical trial lifecycle. Clinion is committed to
innovating the future of clinical trials through AI/ML and
empowering its partners to manage trials more efficiently at lesser
costs.
Contact:
Sudhakar
Patil
P: +91 7337382327
E: sudhakar.patil@clinion.com
Logo -
https://mma.prnewswire.com/media/2456010/Clinion_Award_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/clinion-applauded-by-frost--sullivan-for-enabling-interoperability-and-continuity-in-clinical-trials-management-with-its-eclinical-solutions-302191118.html